Table 3 Univariable analysis of risk factors for leukocyturia (LEU)

Age (1 year increment)

0.9

0.9-1.0

0.59

Gender

Male

63

4

1

Female

133

40

4.7

1.6-13.8

< 0.01

History of tuberculosis

No

144

18

1

Yes

95

25

2.5

1.3-4.9

< 0.01

Hepatitis B positive

No

215

38

1

Yes

12

2

1.0

0.2-5.1

0.93

Hepatitis C positive

No

213

37

1

Yes

13

3

0.7

0.2-2.7

0.60

Body Mass index (0.1 kg/m² increment)

0.9

0.8-0.9

0.03

History of NSAID use

No

116

15

1

Yes

110

29

2.4

1.2-4.8

0.01

Current use of Cotrimoxazole

No

53

2

1

Yes

181

42

7.7

1.8-33.3

< 0.01

Current use of HAART

No

67

7

1

Yes

171

37

2.3

0.9-5.6

0.05

Viral load (log₁₀ copies/ml)

< 1.6

122

29

1

[1.6-3.3]

59

8

0.5

0.2-1.2

[3.3-8]

49

7

0.5

0.2-1.3

0.15

History of aminoglycosides use

No

191

12

1

Yes

19

7

2.7

0.9-7.3

0.05

History of acyclovir use

No

162

27

Yes

59

17

2.0

1.0-4.1

0.04

WHO stage

1

36

2

1

2

48

8

3.7

0.7-18.5

3

122

25

4.4

0.9-19.5

4

28

9

8.0

1.6-41.1

0.03

CD4 (1 cell/mm³ increment)

0.9

0.9-1.0

0.06